Non-registered Executive Jang Hak-sun Acquires 668 Shares via Employee Stock Ownership Plan, Negligible Change in Stake

Pharmicell non-registered executive Jang Hak-sun acquired 668 common shares on June 16, 2026 through the employee stock ownership plan.
His total holdings increased to 4,494 shares, but the ownership ratio remains 0.00% of total outstanding shares of 60,004,014, reflecting a negligible change.
This filing is a routine regulatory disclosure with no material impact on shareholder value, as it involves a minor insider acquisition without capital structure changes.
[AI Summary]This notice is a routine report of an executive's small-scale employee share acquisition, involving no new share issuance or capital alteration, thus having no impact on existing shareholder value. No investment risks or management changes affecting stock price outlook are identified.